Kingdom 23 24  CCW, XJ and XZW contributed equally to this work 25 -2 - † Deceased 26 # Address correspondence to luomh@wh.iov.cn (MHL) or mmn3@st-andrews.ac.uk (MN) 27 -3 -ABSTRACT (141 words) 28 29 The mechanisms underlying neurodevelopmental damage caused by virus infections remain 30 poorly defined. Congenital human cytomegalovirus (HCMV) infection is the leading cause of 31 fetal brain development disorders. Previous work has linked HCMV to perturbations of neural 32 cell fate, including premature differentiation of neural progenitor cells (NPCs). Here we show 33 that HCMV infection of NPCs results in the loss of the SOX2 protein, a key pluripotency-34 associated transcription factor. SOX2 depletion maps to the HCMV major immediate-early 35 (IE) transcription unit and is individually mediated by the IE1 and IE2 proteins. IE1 causes 36 SOX2 down-regulation by promoting the nuclear accumulation and inhibiting the 37 phosphorylation of STAT3, a transcriptional activator of SOX2 expression. Deranged 38 signaling resulting in depletion of a critical stem cell protein is an unanticipated mechanism 39 by which the viral major IE proteins may contribute to brain development disorders caused by 40 congenital HCMV infection.
IMPORTANCE (110 words)
Human cytomegalovirus (HCMV) infections are a leading cause of brain damage, hearing 44 loss and other neurological disabilities in children. We report that the HCMV proteins known 45 as IE1 and IE2 target expression of human SOX2, a central pluripotency-associated 46 transcription factor that governs neural progenitor cell (NPC) fate and is required for normal 47 brain development. Both during HCMV infection and when expressed alone, IE1 causes the 48 loss of SOX2 from NPCs. IE1 mediates SOX2 depletion by targeting STAT3, a critical 49 upstream regulator of SOX2 expression. Our findings reveal an unanticipated mechanism by 50 which a common virus may cause damage to the developing nervous system and suggest 51 novel targets for medical intervention. Congenital human cytomegalovirus (HCMV) infection is the leading cause of birth defects 55 worldwide. Approximately 1% of live newborns are infected in utero with this virus. At the 56 time of birth, 5 to 10% of HCMV-infected newborn infants will exhibit signs of neurological 57 damage, such as microcephaly, cerebral calcification and other abnormal findings (1-3). 58 Among infected newborns that have no symptoms at birth, 10 to 15% subsequently develop 59 central nervous system (CNS) disorders, including sensorineural hearing loss, mental 60 retardation and learning disability (4-6). In addition, some authors have suggested that autism, 61 language disorders and other more subtle changes in brain development might be related to 62 congenital HCMV infection (7-9). 63 Although this virus can infect a wide range of organs in vivo, the fetal brain is regarded 64 the principal target of HCMV infection that results in neurological manifestations (10) (11) (12) . 65 Due to exquisite host-specific tropism of this virus and the lack of animal models that 66 faithfully recapitulate major characteristics of human infection, the pathogenesis of HCMV-67 associated disease in the developing CNS is largely unknown. However, recent advances in 68 human neural progenitor cell (NPC) isolation and culture have provided an opportunity to 69 study HCMV infection in a cell system relevant to fetal neuropathogenesis. Our previous 70 studies and the work of others have shown that human NPCs are susceptible to HCMV 71 infection and fully permissive to viral replication (13) (14) (15) (16) (17) (18) (19) . HCMV infection of NPCs affects 72 the cell fate by causing premature differentiation (14, 17, 18) . Whole-genome analysis 73 demonstrated that HCMV infection modulates the expression of NPC markers (14, 19) 74 including sex-determining region Y (SRY)-box 2 (SOX2), a core transcriptional factor for 75 stem cell self-renewal and pluripotency. 76 -6 -SOX2 is widely expressed in early neuroectoderm and neural progenitor cells during 77 development (14, 19, 20) as well as in neural stem cells in the adult brain (20, 21) . SOX2 78 missense or heterozygous loss-of-function mutations have been identified to cause ocular 79 malformations, often manifesting as anophthalmia, microphthalmia, or coloboma. These 80 symptoms may be accompanied by hearing loss, learning disability, or brain malformation 81 (22) (23) (24) . Familial recurrence of SOX2-associated anophthalmia has been observed (24). 82 Moreover, the level of SOX2 expression plays an important role in sensory organ, including 83 inner ear and retina, development. Groundbreaking research has demonstrated that forced 84 SOX2 expression in fibroblasts, with or without additional factors, can generate induced 85 pluripotent stem cells (25) (26) (27) . In fact, ectopic SOX2 expression directs reprogramming of 86 fibroblasts into neural stem or precursor cells (25, (28) (29) (30) . SOX2 is also critical for 87 maintenance of embryonic stem cells (ESCs). The SOX2 levels in ESCs are tightly regulated 88 (31) and even small changes in expression can lead to differentiation (32, 33) . 89 STAT3 is a member of the signal transducer and activator of transcription family (34) 90 and is expressed in an activated form in the developing CNS as early as during initial NPC 91 proliferation. This protein plays a dichotomous regulatory role in neuro-and gliogenesis (35, 92 36). STAT3 is activated through phosphorylation of tyrosine 705 (Y705) by receptor-93 associated kinases in response to various growth factors and cytokines including interleukin 6 94 (15, 38) . As 107 early as 4 h post infection (hpi), a significant decrease of SOX2 mRNA was observed in 108 NPCs, and this decrease became more apparent as infection progressed ( Fig 1A) . In contrast, 109 SOX2 protein levels did not change in these cells at early post-infection times (up to 12 hpi), 110 but a gradual decrease was observed at late times (from 24 hpi) compared with mock-infected 111 cells ( Fig 1B) . By 48 hpi, the SOX2 protein was clearly down-regulated, and by 96 hpi it was 112 undetectable. The HCMV proteins IE1/IE2, UL44 and gB were also analyzed in this 113 experiment to monitor IE, early, and late viral gene expression, respectively. 114 In addition, the change in SOX2 protein levels was examined in relation to the 115 formation and development of HCMV intranuclear replication compartments visualized via 116 immunofluorescence staining of UL44 ( Fig 1C) . UL44 is the processivity factor of the 117 HCMV DNA polymerase and is first expressed in the early phase of infection. Initially, UL44 118 was evenly distributed across the infected nucleus, then it formed multiple small foci (36 hpi) 119 representing early viral replication compartments, and finally the small foci merged into 120 bipolar foci (48 hpi) or single large late replication compartments (72 hpi, data not shown). In 121 mock-infected NPCs, SOX2 exhibited its typical intense and diffuse nuclear staining. As 122 expected, the SOX2 signal decreased during the course of HCMV infection inversely relating 123 to UL44 foci development. In fact, SOX2 became dispersed and largely disappeared from late 124 HCMV-infected NPCs. 125 These observations indicate the presence of a highly effective mechanism for SOX2 126 depletion in HCMV-infected NPCs. 127 128 SOX2 depletion from HCMV-infected NPCs requires de novo viral protein synthesis. To 129 determine if SOX2 down-regulation is dependent on HCMV gene products expressed de novo 130 from the infecting viral genome, NPCs were exposed to infectious HCMV or UV-inactivated 131 virus and SOX2 expression was analyzed. As expected, SOX2 expression was suppressed at 132 both the RNA and protein level in infections with the untreated virus (Fig 2A and 2B) . In 133 contrast, UV-inactivated virus failed to suppress the expression of SOX2 mRNA (Fig 2A) and 134 protein ( Fig 2B) . Similar levels of glycoprotein B (gB) derived from the input virus were 135 detected at 12 hpi with both untreated and UV-treated HCMV, confirming that cells had been 136 exposed to equal amounts of infecting virus ( Fig 2B) using nucleofection. In agreement with the conclusion that newly synthesized viral proteins 152 mediate SOX2 down-regulation (Fig 2) , SOX2 levels did not change in NPCs transiently 153 expressing pp65 compared to control cells ( Fig 3A) . Thus, pp65 was used as a negative 154 control in subsequent assays. Expression of the entire major IE transcription unit, including 155 the IE1 and IE2 proteins, resulted in significant reduction of SOX2 protein levels ( Fig 3A) . To 156 discriminate between effects on SOX2 expression mediated by IE1 or IE2, each of the two 157 proteins was individually expressed in NPCs. Following transfection of 2 or 5 g IE1 158 expressing plasmid, the relative SOX2 mRNA levels were reduced to 61 or 23% of control 159 levels, and the corresponding protein levels were reduced to 84 or 33%, respectively ( Fig 3B) . 160 Transfection of 2 or 5 g IE2 expressing plasmid reduced the relative SOX2 mRNA levels to 161 71 or 31% of control levels and the protein levels to 88 or 54%, respectively ( Fig 3C) . 162 These results indicate that the HCMV IE1 and IE2 proteins both play a significant role 163 in down-regulating SOX2 expression. However, IE1 appeared to affect SOX2 more efficiently 164 than IE2. Therefore, and because of the lethal phenotype of IE2-deficient viruses (39, 40), we 165 focused our study on the role of IE1 in SOX2 regulation in present study. 166 167 HCMV IE1 is required for depletion of SOX2 during infection of NPCs. HCMV infection 168 and IE1 expression were each sufficient to efficiently down-regulate SOX2 at the mRNA and 169 protein level in NPCs. To confirm the requirement of IE1 for SOX2 depletion during HCMV 170 infection, the expression of IE1 was knocked down using shRNAs targeting IE1 exon 4 171 sequences. First, human embryonic lung (HEL) cells were transduced with lentiviruses 172 expressing shRNAs directed against three different IE1-specific sequences, sh-1 to -3, or a 173 scrambled shRNA control (scr). The transduced cells were subsequently synchronized and 174 infected with HCMV. Analysis of IE1 protein levels determined at 24 and 48 hpi showed that 175 sh-2 was the most efficient among the three tested shRNAs in reducing the levels of the IE1 176 protein ( Fig 4A) . To confirm the knock-down efficiency of sh-2, another experiment was 177 performed where both IE1 mRNA and protein were analyzed at 24, 48 and 72 hpi. Again, sh-2 178 knocked down IE1 by >60% at the RNA level and 50% at the protein level through the course 179 of infection ( Fig 4B) . 180 Following the successful IE1 knock-down in HEL cells, NPCs were transduced with 181 lentiviruses expressing sh-2 or scr. The transduced NPCs were infected with HCMV and 182 collected at 24 to 60 hpi. Since 24 hpi was previously shown to be the "turning point" of 183 SOX2 protein levels (Fig 1) , this time point was chosen as the earliest. As shown in Fig indicated that HCMV IE1 down-regulates SOX2, but a mechanism through which the viral 195 protein alters expression of the cellular stem cell factor has not been identified. Results from 196 co-immunoprecipitation and yeast two hybrid assays failed to provide evidence for a physical 197 interaction between IE1 and SOX2 (data not shown). Since SOX2 expression was affected at 198 both the protein and RNA level, it also seemed more likely that IE1 interferes with 199 transcription rather than protein stability of SOX2. One key transcription factor regulating 200 SOX2 expression is STAT3 (37), which has been recently identified as a physical interaction 201 partner of IE1 (41, 42) . 202 To investigate whether HCMV infection and IE1 expression affect SOX2 levels via 203 modulation of STAT3 activation, the levels of total and tyrosine (Y705)-phosphorylated 204 STAT3 (pSTAT3) were determined in infected NPCs. HCMV infection dramatically 205 suppressed STAT3 tyrosine phosphorylation as early as 4 hpi, and pSTAT3 was maintained at 206 low levels throughout the course of infection as compared to mock-infected NPCs. In 207 contrast, the total STAT3 levels showed little if any changes during infection ( Fig 5A) . 208 STAT3 is a nucleocytoplasmic shuttling protein which is efficiently exported from the 209 nucleus in its unphosphorylated form (43). Unphosphorylated STAT3 is therefore typically 210 located in the cytoplasm or distributed across both the nuclear and cytoplasmic compartments. 211 However, upon tyrosine phosphorylation pSTAT3 efficiently accumulates in the nucleus (37, 212 44, 45). To define the subcellular distribution of STAT3 in HCMV-infected NPCs, we 213 performed immunofluorescence analysis. NPCs on coverslips were infected with HCMV 214 (MOI=1), collected at 8 hpi, and stained for STAT3 and IE1/IE2. STAT3 was mainly confined 215 to the nuclei of virus-infected cells, while in mock-infected cells the STAT3 signal was more 216 diffuse and cytoplasmic as well as nuclear ( Fig 5B) . This observation was consistent with our 217 results from HCMV-infected fibroblasts (41, 42) . To further investigate STAT3 subcellular 218 localization in HCMV-infected NPCs, the levels of pSTAT3 and total STAT3 in cytoplasmic 219 and nuclear compartments separated by cellular fractionation were analyzed at 4 and 8 hpi. 220 GAPDH and lamin B1 served as loading controls for the cytoplasmic and nuclear 221 compartments, respectively, confirming successful fractionation. As expected, pSTAT3 was 222 present predominantly in the nucleus of both mock-and HCMV-infected cells. Compared to 223 mock-infected NPCs, pSTAT3 levels were reduced in both the cytoplasm and nucleus of 224 HCMV-infected cells at 4 and 8 hpi. Total STAT3 resided mainly in the cytoplasm, but the 225 nuclear signal was much stronger in HCMV-infected compared with mock-infected cells at 226 both tested time points ( Fig 5B) . These results indicate that HCMV infection reduces the 227 levels of activated STAT3 (pSTAT3) and promotes the nuclear accumulation of 228 unphosphorylated STAT3 at very early times of infection in NPCs. 229 IE proteins are thought to be the only HCMV gene products expressed at 4 to 8 hpi, 230 when STAT3 is relocalized to the nucleus and its phosphorylation is inhibited. To test whether 231 IE1 was responsible for the observed effects on STAT3, the viral protein was transiently 232 expressed in NPCs. IE1 expression was sufficient to down-regulate pSTAT3 levels and to 233 sequester an unphosphorylated form of the cellular protein in the nuclear compartment (Fig   234   5C ). To further confirm the role of IE1 in altering STAT3 phosphorylation and intracellular 235 localization, NPCs were mock-infected or infected with WT, dlIE1, or rvIE1 viruses. The 236 levels of viral proteins (UL44, gB) were similar, except that IE1 was absent and down-237 regulation of SOX2 was diminished in the infection with dlIE1 ( Fig 5D) . Compared with 238 mock-infected cells, the pSTAT3 levels were reduced in WT-and rvIE1-, but not in dlIE1-239 infected cells. Again, the overall steady-state STAT3 levels were rather constant across all 240 mock-and HCMV-infected samples ( Fig 5E) . Finally, based on cellular fractionation analysis, 241 pSTAT3 was located in the nuclei of both mock-and WT-or dlIE1-infected cells. Total 242 STAT3 localized mainly in the cytoplasm of mock-and dlIE1-infected cells, while increased 243 nuclear localization was observed in WT-infected NPCs ( Fig 5F) . 244 These results demonstrate that IE1 is both sufficient and required for the inhibition of The results thus far obtained are all consistent with a mechanism in which 250 IE1 mediates SOX2 down-regulation by limiting STAT3 activation. To further test this 251 possibility, we performed several different experiments. We first treated NPCs with CTS, a 252 chemical inhibitor of STAT3 tyrosine phosphorylation (46). In the presence of CTS, pSTAT3 253 levels (but not steady-state STAT3 levels) markedly decreased as a function of time of 254 treatment coinciding with gradual loss of SOX2 ( Fig 6A) . Then, STAT3 expression was 255 silenced using RNA interference. Two different shRNAs, shSTAT3-1 and shSTAT3-2, 256 knocked down STAT3 expression with different efficiencies compared to non-specific 257 shRNAs (shLuci and shDsRed). The extent of STAT3 silencing correlated with differential 258 reduction in pSTAT3 levels, in turn correlating with the levels of SOX2 ( Fig 6B) . 259 In addition to the experiments involving inhibition of STAT3, we set out to study the 260 IE1-STAT3-SOX2 axis by activating STAT3 signaling. To this end, we first treated NPCs with 261 IL-6, a major agonist of STAT3 signaling (47). IL-6 treatment led to a marked increase in 262 pSTAT3 without significantly affecting the overall STAT3 protein levels. Concurrent with 263 increased STAT3 tyrosine phosphorylation, there was also a rise in SOX2 levels. These data 264 were consistent with the finding that pSTAT3 promotes SOX2 expression in NPCs ( Fig 6C) . 265 Next, we transiently expressed IE1 in NPCs, treated the cells with IL-6 for 4 h or left them 266 untreated, and analyzed the levels of IE1, pSTAT3, total STAT3 and SOX2. Both pSTAT3 and 267 SOX2 were strongly up-regulated by IL-6, but down-regulated by IE1, and IL-6 efficiently 268 counteracted IE1-mediated down-regulation of pSTAT3 and SOX2. Again, the total steady-269 state STAT3 levels did not significantly change upon IL-6 treatment or IE1 expression ( (48-50). 288 HCMV infection has been shown to induce neural cell loss and abnormal differentiation of 289 NPCs (14, 15, 19 proteins as potential regulators of this stem cell factor. The 72-kDa IE1 and the 86-kDa IE2 308 protein subsequently proved to be sufficient to decrease SOX2 mRNA and protein levels in 309 the absence of other viral proteins, together and individually. IE1 and IE2 are nuclear 310 localized key regulators of viral and cellular transcription during infection (52-54). They have 311 been extensively studied in fibroblasts, but there is little information on how these proteins 312 behave in cell types more relevant to HCMV pathogenesis. 313 Our results demonstrate that the HCMV IE1 protein is not only sufficient, but also 314 necessary for the reduction of SOX2 levels through the early-late stages of infection. As noted 315 above, the down-regulation of SOX2 RNA and protein was also observed with ectopically 316 expressed HCMV IE2, but this protein appeared to be less efficient than IE1 in this respect. 317 We propose that IE2 also contributes to SOX2 down-regulation in the context of HCMV 318 infection, although this remains to be formally shown. Due to the difficulties in working with 319 IE2-deficient viruses (IE2 is essential for HCMV replication and difficult to complement), we 320 focused on IE1 in this study. Our findings may come as a surprise in the light of two previous 321 reports which concluded that HCMV infection or IE1 expression leads to increased instead of 322 decreased SOX2 levels in human glioma stem-like cells, human glioblastoma cells and mouse 323 glioma tissue (55, 56). The seemingly disparate findings might be due to differences in cell 324 types or virus strains. However, in our hands, IE1 induced robust inhibition of STAT3 325 activation in all cell types tested so far including glioblastoma-derived cell lines (data not 326 shown). Notably, the previous studies did not discriminate between the levels of SOX2 in IE1 327 expressing cells and IE1-negative cells in the same culture or tumor. Even if the STAT3 328 pathway is inhibited in HCMV-infected cells or cells ectopically expressing IE1, the 329 secretome associated with these cells may trigger STAT3 signaling in IE1-negative bystander 330 cells. In population analyses, this bystander effect may be detected as an overall increase in 331 STAT3-dependent gene expression (42). 332 Our work also determines the molecular events underlying IE1-dependent SOX2 down- All cells were maintained at 37°C in a humidified atmosphere containing 5% CO 2 . NPCs 370 were isolated as described previously (38, 58) and cultured in a 1:1 mix of growth medium 371 and conditioned medium (14, 15, 19) . The NPC growth medium was Dulbecco's Modified 372 Eagle Medium (DMEM)-F12 (Thermo Fisher Scientific) supplemented with 2 mM 373 GlutaMAX (Thermo Fisher Scientific), 100 U/ml penicillin and 100 µg/ml streptomycin 374 (Thermo Fisher Scientific), 50 g/ml gentamycin (Sigma), 1.5 g/ml amphotericin B 375 (Thermo Fisher Scientific), 10% BIT 9500 (Stem Cell Technologies), 20 ng/ml epidermal 376 growth factor (EGF, Prospec) and 20 ng/ml basic fibroblast growth factor (FGF, Prospec). 377 Conditioned medium was collected from cultured NPCs and stored at -20C after cell debris 378 had been removed by centrifugation. NPCs were maintained as monolayers in fibronectin-379 coated dishes and seeded at a defined density into dishes coated with poly-D-lysine (50 μg/ml, 380 Millipore) prior to infection. In order to induce STAT3 activation, NPCs were treated with 381 carrier-free recombinant human IL-6 (183 ng/ml, Biolegend) for the indicated times before 382 being collected for protein analysis. To inhibit STAT3 activation, NPCs were treated for the 383 indicated times with 10 μM cryptotanshinone (CTS, Sigma), a small molecular inhibitor of 384 STAT3 tyrosine (Y705) phosphorylation. 385 Human embryonic lung fibroblasts (HEL cells, maintained in the laboratory) and HEL 386 cells immortalized by transfection with pCI-neo-hTERT (HELf cells, kindly provided by Dr. 387 Chen, Columbia University), were cultured in Minimal Essential Medium (MEM, Thermo (61). UV-inactivated HCMV was prepared by exposure to 6000 J/cm 2 in a 452 CL-1000 Ultraviolet Crosslinker (UVP), sodium pyruvate was added to a final concentration 453 of 5 mM to prevent damage from free radicals induced by ultraviolet radiation (62). 454 For NPC infections, confluent cell monolayers on fibronectin-coated dishes were 455 dissociated using Accutase (Millipore), 3×10 6 cells were reseeded in poly-D-lysine-coated 456 100-mm dishes or uncoated dishes with poly-D-lysine-coated coverslips, and cells were 457 -23 -allowed to attach overnight. Cells were exposed to HCMV at the indicated multiplicities of 458 infection (MOIs). For the evaluation of IE1-directed shRNAs, NPCs or HEL cells were 459 infected with HCMV at an MOI of 1. To overcome the delay of infection process of TNdlIE1, 460 MOI of 10 was used. After incubation for 3 h to allow for virus adsorption, the inoculum was 461 removed and cells were refed with fresh medium. Cells were collected and analyzed at the 462 indicated times post infection. To study infection in the absence of de novo protein synthesis, 463 NPCs were pretreated with 10 μg/ml cycloheximide (CHX, Sigma) for 1 h prior to infection, 464 infected with HCMV in the presence of CHX (10 μg/ml), and collected at 16 hpi for RNA and 465 protein analysis.
467
Lentivirus preparation and transduction 468 Stocks of replication-defective lentiviruses were prepared as described previously (57, 63). 469 Briefly, 1.5×10 6 HEK 293T cells were seeded in a 100-mm dish. On the next day, calcium 470 phosphate precipitation was applied to cotransfect the cells with packaging plasmids pML-471 Δ8.9 (12 µg) and pVSV-G (8 µg) (System Biosciences) along with 15 μg of one of the 472 following expression plasmids: pCDH-puro-IE1, pLKO.1-scramble, pLKO.1-shRNA-IE1-1, 473 pLKO.1-shRNA-IE1-2, pLKO.1-shRNA-IE1-3, Tet-pLKO-puro-shDsRed, Tet-pLKO-puro- 474 shLuci, Tet-pLKO-puro-shSTAT3-1, or Tet-pLKO-puro-shSTAT3-2. Following a medium 475 change, the lentivirus containing supernatants were collected 72 h after transfection and stored 476 at -80C. 477 The lentivirus stocks were used to transduce HEL cells, HELf cells, or NPCs. To this 478 end, 5×10 6 NPCs were seeded in fibronectin-coated dishes and infected with equal volumes (2 479 ml) of lentivirus stock on the following day. Lentivirus stock was added to the NPCs again on 480 the next day. The inoculum was replaced with fresh culture medium 3 h after each 481 transduction. Likewise, 5×10 5 HEL cells were infected with 2 ml lentivirus stock on the day 482 following seeding, and the inoculum was replaced with fresh culture medium 5 h after 483 infection. The transduced cells were cultured for 3 days to allow for transgene expression, 484 before they were subjected to HCMV infection and/or RNA or protein analysis. The 485 transduction procedure used to establish HELf-IE1 cells is described above.
487
Gene silencing with shRNAs 488 To determine the IE1-specific silencing efficiency, equal amounts of shRNA expressing 489 lentiviruses (sh-1, sh-2, sh-3, and scr) were used to transduce HEL cells in parallel. The 490 resulting HEL cells were cultured for 2 days to allow for shRNA expression, and this was 491 followed by 2 days serum starvation with serum free medium to synchronize the cells. The 492 synchronized cells were reseeded in 60-mm dishes (1×10 6 cells/dish), allowed to attach, and 493 infected with HCMV (MOI = 1). The infected cells were collected at 24 and 48 hpi, and the 494 levels of IE1 were determined by protein analysis. After selection of the most efficient shRNA 495 (sh-2), NPCs were transduced with sh-2 and scr lentiviruses in parallel. Transduced NPCs 496 were cultured for 48 h to allow for shRNA expression, reseeded in poly-D-lysine-coated 497 dishes (3×10 6 cells/dish), and infected with HCMV (MOI = 1) on the following day. Cells 498 were collected at the indicated times post infection and subjected to protein and RNA 499 analysis. 500 NPCs transduced with shRNA expressing lentiviruses Tet-pLKO-puro-shDsRed, Tet-501 pLKO-puro-shLuci, Tet-pLKO-puro-shSTAT3-1, or Tet-pLKO-puro-shSTAT3-2 (described 502 above) were treated with 1 μg/ml doxycycline hyclate (Dox, Aladdin) for 48 h, with a medium 503 change after 24 h, to induce shRNA expression. Cells were collected and analyzed at the 504 indicated times. Table 1 . Amplification 515 was performed by denaturation at 95°C for 5 min, followed by 35 two-step cycles of 95°C for 516 10 s and 60°C for 30 s. Melting curve analysis was carried out at 95°C for 1 min, 55°C for 1 517 min, and 55 to 95°C for 10 s. Each reaction was performed in triplicate, and results for the 518 target gene mRNA were normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 519 using the 2 ΔΔCT method. Three independent experiments were performed, and results are 520 presented as the means  one standard deviation (SD). Data were statistically evaluated using 521 the Student's t-test. A P-value of 0.05 was considered statistically significant. 
